Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
RefMet: Metabolite Nomenclature
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Clustering data with hclust algorithm for (Study ST002726)
Reversed phase NEGATIVE ION MODE (Analysis AN004418)
Metabolite
Structure
F1
F2
F3
Arachidonic acid (Eicosatetraenoic acid)
ME704622
1.86
0.86
0.35
L-aspartate
ME704559
0.68
0.52
1.73
Dihomo-gamma-linolenic acid ((8Z-11Z-14Z)-Icosatrienoic acid)
ME704625
1.71
0.98
0.37
1D-myo-Inositol 1-4-bisphosphate
ME704605
0.45
1.09
1.35
UMP
ME704566
0.94
0.83
1.10
Urate
ME704570
0.98
1.08
0.94
ADP-D-ribose
ME704573
2.14
1.08
0.77
Pentanoate (valerate)
ME704608
0.93
1.01
1.05
Thymidine
ME704564
1.00
0.81
1.17
2-Oxoglutarate
ME704587
0.14
2.81
0.24
Docosahexaenoic acid
ME704623
1.90
0.78
0.38
Tetradecenoic acid (myristoleic acid)
ME704617
1.33
0.96
0.73
D-Glyceraldehyde 3-phosphate/Glycerone phosphate
ME704579
0.48
0.55
1.88
Hexadecanoic acid (palmitic acid)
ME704615
1.43
0.99
0.62
Octadecenoic acid (Oleic acid)
ME704619
1.63
0.85
0.56
Phosphate
ME704574
1.17
0.89
0.95
Hexadecenoic acid (Palmitoleic acid)
ME704618
1.35
0.83
0.84
Succinate
ME704588
0.94
1.03
1.03
Glutathione disulfide
ME704594
0.53
0.44
1.56
3-Phosphonooxypyruvate
ME704598
1.02
1.00
0.99
Pyruvate
ME704582
0.93
0.96
1.10
UDP
ME704565
0.90
0.95
1.14
Docosapentaenoic acid ((7Z-10Z-13Z-16Z-19Z)-Docosa-7-10-13-16-19-pentaenoic acid)
ME704626
1.75
0.98
0.33
Heptanoic acid
ME704609
1.05
0.99
0.96
ATP
ME704560
0.30
0.79
1.63
Taurine
ME704603
0.94
0.64
1.27
Dodecanoic acid (lauric acid)
ME704613
1.17
0.93
0.91
5-10-Methenyltetrahydrofolate
ME704599
1.14
0.91
0.96
Decanoic acid (capric acid)
ME704612
1.06
0.90
1.04
Ascorbate
ME704596
1.29
0.38
1.30
Malate
ME704590
0.67
0.88
1.41
5-Phospho-alpha-D-ribose 1-diphosphate
ME704593
1.03
1.04
0.94
1-3-Bisphosphoglycerate
ME704580
1.05
0.83
1.11
Octadecanoic acid (stearic acid)
ME704616
1.06
1.15
0.81
CTP
ME704563
1.14
0.98
0.89
Dehydroascorbate
ME704597
0.23
0.51
2.14
IDP
ME704567
0.82
1.05
1.12
Diphosphate
ME704575
1.67
0.64
0.68
Dihydrofolate
ME704600
0.92
0.92
1.16
GMP
ME704562
1.29
0.84
0.98
Ornithine
ME704601
0.67
0.84
1.44
1-4-beta-D-Xylan
ME704602
1.03
0.94
1.02
Lactate
ME704583
0.95
0.95
1.08
alpha-D-Ribose 1-phosphate
ME704592
0.88
0.80
1.19
L-Cysteate
ME704604
1.02
1.06
0.93
Octanoic acid (caprylic acid)
ME704610
0.96
1.20
0.85
UDP-glucose
ME704572
0.48
0.90
1.19
Citrate
ME704586
0.23
0.79
1.89
Linoleic acid ((9Z,12Z)-Octadecadienoic acid)
ME704620
1.76
0.80
0.50
Tetradecanoic acid (myristic acid)
ME704614
1.16
0.98
0.87
a-Linolenic acid (Octadecatrienoic acid)
ME704621
1.71
0.72
0.61
Ethanolamine phosphate
ME704606
0.57
0.32
1.83
D-Glucose 6-phosphate
ME704577
0.77
0.71
1.28
Mannitol
ME704584
0.83
1.05
1.11
Nonanoic acid (pelargonic acid)
ME704611
1.02
0.89
1.08
Xanthine
ME704568
0.92
0.80
1.20
2/3-Phospho-D-glycerate
ME704581
0.77
0.65
1.37
5-Oxoproline
ME704595
0.56
0.68
1.69
Butanoic/Butyric acid
ME704607
0.98
1.07
0.95
5-Hydroxyisourate
ME704569
0.85
1.09
1.05
Eicosapentaenoic acid
ME704624
0.95
1.16
0.90
3^,5^-Cyclic IMP
ME704571
0.77
1.14
1.08
2-Hydroxyglutarate/Citramalate
ME704591
0.51
0.91
1.53
D-Fructose 1-6-bisphosphate
ME704578
0.41
1.14
1.41
D-Glucose
ME704576
1.02
0.98
1.00
Fumarate
ME704589
0.66
0.88
1.43
ADP
ME704561
0.64
0.56
1.33
D-Ribose
ME704585
0.98
0.99
1.03
Factors:
F1
Factor:Berk
F2
Factor:Beta Thal
F3
Factor:WT
Data matrix
UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
This repository is under review for potential modification in compliance with Administration directives
Terms of use
Site map
Contact
NMDR Personnel